ArticleFrontiers in oncology2022

ASF1B: A Possible Prognostic Marker, Therapeutic Target, and Predictor of Immunotherapy in Male Thyroid Carcinoma.

Weigang Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.